The Food and Drug Administration (FDA) has, for the third time, declined approval of the long-acting testosterone undecanoate injection product (Aveed, Endo Pharma Solutions) for the treatment of men ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results